Diuretic Drug Use and the Risk for Hip Fracture
Overview
Authors
Affiliations
Objective: To test the hypothesis that use of thiazide diuretics prevents hip fracture and to study the risk for hip fracture associated with furosemide use.
Design: A case-control study.
Setting: Hospitals owned by a health maintenance organization in Washington.
Patients: Elderly patients (n = 462) hospitalized because of a hip fracture between 1977 and 1983 and an equal number of age- and sex-matched population-based control patients.
Measurements: Use of thiazide diuretics and furosemide was ascertained from medical records and computerized pharmacy records. The relative risk for hip fracture associated with diuretic use was calculated and adjusted for the potentially confounding effects of nursing home residence; previous hospitalizations; a history of stroke, alcoholism, or the organic brain syndrome; body weight; leg paralysis; and use of phenobarbital, corticosteroids, or other diuretics. Current and former users of diuretics were analyzed separately.
Main Results: The adjusted risk for hip fracture was 1.6 (95% CI, 1.0 to 2.5) for current thiazide users. The adjusted risk for hip fracture for current furosemide use was 3.9 (CI, 1.5 to 10.4).
Conclusions: According to this study, use of thiazide diuretics did not protect against hip fracture and cannot be recommended for fracture prevention. Current furosemide use was also associated with hip fracture.
Shukuri T, Nakai K, Tanaka S, Yamada S, Tokumoto M, Tsuruya K Clin Exp Nephrol. 2023; 27(11):919-927.
PMID: 37498346 DOI: 10.1007/s10157-023-02385-3.
Traditional and Non-traditional Risk Factors for Osteoporosis in CKD.
Jorgensen H, David K, Salam S, Evenepoel P Calcif Tissue Int. 2021; 108(4):496-511.
PMID: 33586002 DOI: 10.1007/s00223-020-00786-0.
Thiazide Use and Fracture Risk: An updated Bayesian Meta-Analysis.
Charkos T, Liu Y, Jin L, Yang S Sci Rep. 2019; 9(1):19754.
PMID: 31874989 PMC: 6930249. DOI: 10.1038/s41598-019-56108-4.
Increased Fracture Risk with Furosemide Use in Children with Congenital Heart Disease.
Heo J, Rascati K, Lopez K, Moffett B J Pediatr. 2018; 199:92-98.e10.
PMID: 29753543 PMC: 6733257. DOI: 10.1016/j.jpeds.2018.03.077.
Mohn E, Kern H, Saltzman E, Mitmesser S, McKay D Pharmaceutics. 2018; 10(1).
PMID: 29558445 PMC: 5874849. DOI: 10.3390/pharmaceutics10010036.